We are live on
!
Find out more
MAM
Myriad Asset Management Portfolio holdings
AUM
$722M
1-Year Est. Return
11.94%
This Fund
S&P 500
This Quarter
Est. Return
+2.42%
1 Year Est. Return
+11.94%
3 Year Est. Return
+148.96%
5 Year Est. Return
+248.9%
10 Year Est. Return
–
AUM
$1.44B
AUM Growth
-$130M
(-8.2%)
Cap. Flow
-$1B
Cap. Flow
% of AUM
-69.4%
Top 10 Holdings %
Top 10 Hldgs %
62.44%
Holding
63
New
11
Increased
–
Reduced
13
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$18.1M |
| 2 |
FTRPR
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
|
+$15.3M |
| 3 |
HDFC Bank
HDB
|
+$12.1M |
| 4 |
Electronic Arts
EA
|
+$9.74M |
| 5 |
AHPAU
Avista Healthcare Public Acquisition Corp.Units
AHPAU
|
+$5.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$51.8M |
| 2 |
New Oriental
EDU
|
+$51.5M |
| 3 |
Amazon
AMZN
|
+$35.6M |
| 4 |
WUBA
58.com Inc
WUBA
|
+$17.3M |
| 5 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$16.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.29% |
| 2 | Communication Services | 7.97% |
| 3 | Financials | 0.76% |
| 4 | Healthcare | 0.11% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
BioMarin Pharmaceuticals
BMRN
$11.9B
| $431K | 0.03% |
+5,200
| New | +$447K |
|
|
27
Amazon
AMZN
$2.44T
| – | – |
-850,000
| Closed | -$35.6M |
|
28
Alibaba
BABA
$276B
| – | – |
-55,495
| Closed | -$5.87M |
|
29
Salesforce
CRM
$154B
| – | – |
-18,150
| Closed | -$1.29M |
|
|
30
New Oriental
EDU
$9.32B
| – | – |
-1,111,152
| Closed | -$51.5M |
|
31
Trimble
TRMB
$13.6B
| – | – |
-370,786
| Closed | -$10.6M |
|
|
IPHI
32
DELISTED
INPHI CORPORATION
IPHI
| – | – |
-57,899
| Closed | -$2.52M |
|
|
RYAM.PRA
33
DELISTED
Rayonier Advanced Materials Inc. 8.00% Series A Mandatory Convertible Preferred Stock
RYAM.PRA
| – | – |
-50,000
| Closed | -$5.22M |
|
|
AGN.PRA
34
DELISTED
Allergan plc
AGN.PRA
| – | – |
-20,000
| Closed | -$16.4M |
|
|
CBPO
35
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| – | – |
-133,913
| Closed | -$16.7M |
|
|
IM
36
DELISTED
Ingram Micro
IM
| – | – |
-145,897
| Closed | -$5.2M |
|
Similar funds
JIM
LWA
TM
LSGA
MFP
HAM
HT
MFW
Myriad Asset Management's Q4 2016 Portfolio in Review
As of Q4 2016, Myriad Asset Management held 63 positions worth $1.44B, down 8.2% from $1.57B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Myriad Asset Management withdrew a net $1B in Q4 2016, closing 11 positions and reducing 13 holdings. Its most notable exit was New Oriental, an estimated $51.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Communication Services and Financials.
Against the trend, Myriad Asset Management opened a new position in T-Mobile US worth $19.9M.
- Myriad Asset Management's largest Q4 2016 buy was T-Mobile US: 345,200 shares worth $19.9M.
- Myriad Asset Management's biggest Q4 2016 reduction was Alphabet (Google) Class A, cutting an estimated $51.8M.
- Myriad Asset Management fully exited New Oriental in Q4 2016, selling an estimated $51.5M.
- Myriad Asset Management's ten largest holdings make up 62% of its $1.44B portfolio in Q4 2016.
- Myriad Asset Management opened 11 new positions and closed 11 in Q4 2016.
- Myriad Asset Management's portfolio value fell 8.2% quarter-over-quarter to $1.44B.
Based on Myriad Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.